News
BLCO
21.14
-0.02%
-0.01
Best Growth Stocks to Buy for November 13th
NASDAQ · 12h ago
Best Growth Stocks to Buy for November 11th
NASDAQ · 2d ago
Weekly Report: what happened at BLCO last week (1102-1106)?
Weekly Report · 4d ago
Best Growth Stocks to Buy for November 9th
NASDAQ · 4d ago
Should Raised Revenue Guidance Require Action From Bausch + Lomb Stock Investors?
Simply Wall St · 5d ago
Can Bausch + Lomb (BLCO) Justify Its Valuation As Profitability Returns?
Simply Wall St · 6d ago
Zacks.com featured highlights include Repsol, Bausch + Lomb, DMC Global, Universal Logistics and Methanex
NASDAQ · 11/06 14:29
Bausch + Lomb (BLCO) Stock Could Be Cheap After Its 28% Gain
Simply Wall St · 11/06 12:36
Bausch + Lomb: Profits Return In Q3 As A Recovery Story, While Pipeline Grows
Seeking Alpha · 11/06 07:48
Stocks To Consider Ahead Of The Upcoming October 2026 CPI Report
Seeking Alpha · 11/05 20:12
Are You Looking for a Top Momentum Pick? Why Bausch + Lomb (BLCO) is a Great Choice
NASDAQ · 11/05 16:00
Best Growth Stocks to Buy for November 5th
NASDAQ · 11/05 06:16
Bausch + Lomb: 3 Key Takeaways for Long-Term Investors
NASDAQ · 11/05 00:48
Why Bausch + Lomb (BLCO) Might be Well Poised for a Surge
NASDAQ · 11/04 16:20
Most and least shorted mid- to mega-cap healthcare stocks at the end of October
Seeking Alpha · 11/03 15:00
Bausch + Lomb Consensus Price Target Raised 10.44% to $21.92
NASDAQ · 11/02 15:48
This Coinbase Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
Benzinga · 11/02 13:27
HC Wainwright & Co. Downgrades Bausch & Lomb to Neutral, Raises Price Target to $22
Benzinga · 11/02 11:25
Bausch + Lomb downgraded to Neutral from Buy at H.C. Wainwright
TipRanks · 11/02 11:10
New Strong Buy Stocks for November 2nd
NASDAQ · 11/02 10:34
More
Webull provides a variety of real-time BLCO stock news. You can receive the latest news about Bausch + Lomb Corporation through multiple platforms. This information may help you make smarter investment decisions.
About BLCO
Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.